Adding to the pile of research linking COVID-19 and vascular issues, a new study indicates that venous thromboembolism ... The cholesterol-lowering PCSK9 inhibitor alirocumab reduced the risk for a second heart in patients who had survived ... Ultra-thin strut drug-eluting stents (DES) may promote better clinical outcomes than thicker strut second-generation DES ...